Sky Century Investment (SKYI) Cash & Current Investments (2012 - 2026)

Sky Century Investment's (SKYI) quarterly Cash & Current Investments came in at $264.0 in Q2 2026, down 97.67% year-on-year from $11312.0 in Q2 2025, and down 92.14% on a QoQ basis from $3360.0 in Q1 2026.

Sky Century Investment (SKYI) Cash & Current Investments (2012 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 5 years of Cash & Current Investments data on file, last reported at $264.0 in Q2 2026.

  • On a quarterly basis, Cash & Current Investments fell 97.67% year-over-year to $264.0 in Q2 2026; TTM through May 2026 was $264.0, a 97.67% decrease from a year earlier, with the FY2025 full-year figure at $477.0, changed N/A from the prior year.
  • Cash & Current Investments for Q2 2026 stood at $264.0, down from $3360.0 in the prior quarter.
  • Over the last five years, Cash & Current Investments for SKYI reached as high as $11312.0 in Q2 2025 and fell as low as $264.0 in Q2 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 428.00 Mn
10 Sky Century Investment 944,514.46 944,250.46 26,045.00 264.00

Historic Data

Download Data
DateValue
May 31, 2026 264.00
Feb 28, 2026 3,360.00
Nov 30, 2025 467.00
Aug 31, 2025 477.00
May 31, 2025 11,312.00
Aug 31, 2014 515.00
May 31, 2014 515.00
Feb 28, 2014 515.00
Nov 30, 2013 5,565.00
Aug 31, 2013 479.00
May 31, 2013 154.00
Feb 28, 2013 154.00
Aug 31, 2012 854.00